Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01542866 · ClinicalTrials.gov registry record · NA
A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)
A NA study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT01542866 is a NA study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 160 participants.
The verdict
NCT01542866, a NA study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
This is a prospective pilot study to evaluate the usability and applicability of a self monitoring test of visual function with the handheld Health Management Tool (HMT) to remotely monitor neovascular Age Related Macular Degeneration (AMD) to detect a potential change in disease status.
Interventions
- OTHER Health Management Tool (HMT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2011-01-11 |
| Est. Completion | 2011-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01542866
The ClinicalTrials.gov registry entry for NCT01542866 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Health Management Tool (HMT) is the first listed.
NCT01542866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01542866 about?
NCT01542866 is a clinical study titled "A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)". This is a prospective pilot study to evaluate the usability and applicability of a self monitoring test of visual function with the handheld Health Management Tool (HMT) to remotely monitor neovascular Age Related Macular Degeneration (AMD) to detect a potential change in disease status.
What is the current status of trial NCT01542866?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2011-01-11. Estimated completion is 2011-11-30.
What interventions are being tested in trial NCT01542866?
The interventions under investigation include: Health Management Tool (HMT) (OTHER).
Who is sponsoring clinical trial NCT01542866?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.